1. ASD patients showed improved survival post-cancer treatment.
2. Significant findings for alopecia areata and Sjögren syndrome.
3. Study involved 197,895 cancer patients.
4. Lower rates of mortality in ASD group.
5. Results consistent across cancer stages and treatments.
6. Immune mechanisms may influence cancer outcomes.
7. Negative control with burn injury showed no ASD association.
8. Further research needed on immunologic factors and cancer management.

Source: JAMA Dermatology